BioLineRx (BLRX) Non-Current Assets (2010 - 2026)
BioLineRx's Non-Current Assets came in at $17.13 million for the quarter ended Jun 30, 2026, up 50.2% from $11.41 million a year earlier but down 0.5% from the prior quarter.
Powered by 
Analysis
BioLineRx (BLRX) Non-Current Assets (2010 - 2026) Analysis & Trends
As of Dec 31, 2025, BioLineRx's Non-Current Assets was $17.22 million, up 45.9% from the prior year.
- Non-Current Assets carries a five-year compound annual growth rate of -6.7% (years ended Dec 2020 to Dec 2025).
- Going back by year, Non-Current Assets was $11.8 million in the year ended Dec 31, 2024 (-29.5%), $16.74 million in the year ended Dec 31, 2023 (-31.3%), $24.38 million in the year ended Dec 31, 2022 (+1.7%) and $23.99 million in the year ended Dec 31, 2021 (-1.7%).
- The five-year range for quarterly Non-Current Assets is $11.28 million (the quarter ended Sep 30, 2025) to $24.38 million (the quarter ended Dec 31, 2022).
- Year-over-year, Non-Current Assets has increased for three consecutive quarters, with an average decline of 0.1% over the last eight quarters.
- The fastest year-over-year change in Non-Current Assets over five years came in the quarter ended Jun 30, 2026 (growth of 50.2%), and the weakest in the quarter ended Sep 30, 2024 (a decline of 38.1%).
- Business Quant data shows BLRX's Non-Current Assets at $17.22 million (quarter ended Mar 31, 2026), $17.22 million (quarter ended Dec 31, 2025) and $11.28 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | BioLineRx | 6.34 Bn | 6.35 Bn | 235,000.00 | 17.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.13 Mn |
| Mar 31, 2026 | 17.22 Mn |
| Dec 31, 2025 | 17.22 Mn |
| Sep 30, 2025 | 11.28 Mn |
| Jun 30, 2025 | 11.41 Mn |
| Mar 31, 2025 | 11.59 Mn |
| Dec 31, 2024 | 11.80 Mn |
| Sep 30, 2024 | 14.89 Mn |
| Jun 30, 2024 | 15.49 Mn |
| Mar 31, 2024 | 15.91 Mn |
| Dec 31, 2023 | 16.74 Mn |
| Sep 30, 2023 | 24.05 Mn |
| Jun 30, 2023 | 24.24 Mn |
| Mar 31, 2023 | 24.32 Mn |
| Dec 31, 2022 | 24.38 Mn |
| Sep 30, 2022 | 23.73 Mn |
| Jun 30, 2022 | 23.74 Mn |
| Mar 31, 2022 | 23.83 Mn |
| Dec 31, 2021 | 23.99 Mn |
| Sep 30, 2021 | 24.06 Mn |
API Access
BioLineRx Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();